NovoPath releases integrated workflows for genetic and molecular testing

Oct. 5, 2022
NovoPath announcement.

NovoPath LLC announced the release of enhanced integrated workflows for genetic and molecular testing.

NovoPath 360 is bridging the gap between Pathologists and Oncologists by providing an enhanced SaaS-based LIS platform empowering diagnostic labs to effortlessly add molecular and genomic ancillary tests to anatomic workflows. Consequently, providing physicians comprehensive, easy to read reports that present the interpretation and impact of all tests in a single file. Additional NovoPath360 enhancements include:

  • Single Case, Single Report
  • Preconfigured Workflows
  • Role-Based Permissions
  • Customizable User Views
  • Advanced Admin Area

Read the full release here